HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A retrospective study of the probability of the evolution of parapsoriasis en plaques into mycosis fungoides.

Abstract
Parapsoriasis en plaque has been suggested to be an early manifestation of mycosis fungoides (cutaneous T-cell lymphoma). We explored the disease course of patients with small plaque or large plaque parapsoriasis in a 26-year retrospective cohort analysis of 105 parapsoriasis patients, who were clinically and histopathologically followed up in Helsinki and Tampere University Hospitals. Eventual later cancers of these patients were verified from the Finnish Cancer Registry. In the small plaque parapsoriasis group, 7 patients (10%) and in the large plaque parapsoriasis group 12 patients (35%), developed histologically confirmed mycosis fungoides during a median of 10 and 6 years, respectively. No significant differences were found regarding the risk of developing mycosis fungoides or the tendency to remission in patients treated with or without phototherapy. Our results show that not only large plaque parapsoriasis, but also small plaque parapsoriasis, as currently defined in textbooks, can progress to mycosis fungoides. The benefits of phototherapy are equivocal in parapsoriasis treatment as far as progression to cancer is concerned.
AuthorsLiisa Väkevä, Seppo Sarna, Annikki Vaalasti, Eero Pukkala, Arja-Leena Kariniemi, Annamari Ranki
JournalActa dermato-venereologica (Acta Derm Venereol) Vol. 85 Issue 4 Pg. 318-23 ( 2005) ISSN: 0001-5555 [Print] Sweden
PMID16191852 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Aged
  • Cell Transformation, Neoplastic
  • Cohort Studies
  • Female
  • Finland (epidemiology)
  • Humans
  • Male
  • Middle Aged
  • Mycosis Fungoides (drug therapy, epidemiology, etiology, pathology)
  • PUVA Therapy
  • Psoriasis (complications, pathology)
  • Registries
  • Retrospective Studies
  • Skin Neoplasms (drug therapy, epidemiology, etiology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: